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Abstract
Guthikonda, Kranthi. MPH. The University of Memphis. May, 2014. Oral contraceptives
modify the effect of GATA3 polymorphisms on the risk of asthma at age 18 years via
DNA methylation. Major Professor: Wilfried Karmaus.
Prevalence of asthma is higher in boys than girls before puberty, while a shift between
the genders is found after the puberty. However, the actual mechanism behind this gender
shift is not yet clear. We hypothesize that, in girls, oral contraceptive (OCP) use and age
at menarche modify the effect of GATA3 polymorphisms on the risk of asthma at age 18
via DNA methylation. Blood samples were collected at age 18 years from 245 female
participants randomly selected for methylation analysis from the Isle of Wight birth
cohort, UK. In the first stage, OCP use and age at menarche in interaction with rs1269486
were significantly associated with differential methylation of cg17124583, which
subsequently modified the association of rs422628 with the risk for asthma at age 18
years. A two-stage model consisting of genetic variants in the GATA3 gene, OCP use, age
at menarche, and DNA methylation may explain how female sex hormones can be linked
to explain the gender differences in asthma before and after puberty.
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Introduction
Asthma is a complex, multifactorial disease that is influenced by the interplay between
genetic and environmental factors. Studies have shown that the prevalence of asthma is
higher in boys than girls before puberty, while a shift between the genders is found after
puberty (Postma, 2007; Soto-Ramirez et al., 2013; Tollefsen et al., 2007; Wada,
Okuyama, Ohkawara, Takayanagi, & Ohno, 2010). The actual mechanism behind this
gender switch is not yet clear. In addition, some studies suggest that asthma and lung
function vary during different phases of the menstrual cycle, suggesting a role of sex
hormones in asthma (Balzano, Fuschillo, Melillo, & Bonini, 2001; Siroux, Curt,
Oryszczyn, Maccario, & Kauffmann, 2004; Tam et al., 2011). The biological effects of
female sex hormones estrogen and progesterone include a decrease in the contractility
and thus an increase in the relaxation of airway smooth muscles (Haggerty, Ness, Kelsey,
& Waterer, 2003). Progesterone is considered to stimulate the IL-4 production and
promotes the development of human Th2 cells (Piccinni et al., 1995). Immunological
effects of estrogen include increased production of TNF-α by the lungs, increased
production of IL-4 by the bone marrow and thus migration of eosinophils during allergic
inflammation (Ana Paula Ligeiro de Oliveira, Adriana Lino dos Santos Franco, &
Bernardo Boris Vargaftig, 2007), decreased expression of T-regulatory cells (Arruvito,
Sanz, Banham, & Fainboim, 2007), and increased expression of IL-5 and IL-13 (Cai,
Zhou, & Webb, 2012), differentiation of naive CD4+ cells in to type 2 T helper (Th2)
cells (Cai et al., 2012), and Th2 responses by augmenting the production of dendritic
cells (Uemura, Liu, Narita, Suzuki, & Matsushita, 2008). Hence, estrogen may be linked
to potential immunological effects and variations in airway responses. In addition, it has
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been reported that both exogenous and endogenous sex hormones influence the
occurrence of asthma in young women (Salam, Wenten, & Gilliland, 2006).
Oral contraceptive pills (OCPs) are exogenous sex hormone preparations used by
adolescent girls for irregular menstruation, hirsutism, polycystic ovarian disease,
dysmenorrhoea, and primarily for birth control. There are limited and conflicting reports
on the association between OCPs and asthma. One study has shown that OCPs
diminished the hormonal fluctuations and decreased the exacerbation of symptoms in
women with asthma (Tan, McFarlane, & Lipworth, 1997). In an another study, OCPs
were considered to increase the total lung capacities in non-asthmatic women during the
follicular but not during the luteal phases of the menstrual cycle (Seaton, 1972). More
wheezing among non-asthmatics and less wheezing among asthmatics it has been
reported for women who use OCPs (Salam et al., 2006). Additionally, an increased
production of suppressor T cells is reported in asthmatic women taking OCPs (VelezOrtega et al., 2013). Finally, one study in premenopausal women reported no association
between the use of OCPs and asthma (Lange, Parner, Prescott, Ulrik, & Vestbo, 2001).
Some studies found early menarche to be associated with the risk of adult asthma (AlSahab, Hamadeh, Ardern, & Tamim, 2011; Macsali et al., 2011; Salam et al., 2006),
while other studies reported no association (Burgess et al., 2007; Jartti et al., 2009).
Overall, there is a lack of understanding of the association between age at menarche, sex
hormones, and asthma.
The transcription factor GATA3, located on chromosome 10, is a master regulator of
Th2 cell differentiation (Zheng & Flavell, 1997) and plays an important role in the
production of cytokines (Lee et al., 2000; Zhu et al., 2004). A study by Wada et al in a
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mouse model of asthma demonstrated that there is an increased production of antigen
induced Th2 cytokines from the bronchial lymph node cells of female mice and that this
was associated with enhanced GATA3 expression, compared to male mice (Wada et al.,
2010), suggesting a possible role of GATA3 in asthma specific to females.
The term epigenetics refers to the study of changes in phenotype or expression of
genes that are not due to changes in the sequence of DNA (Egger, Liang, Aparicio, &
Jones, 2004). Epigenetics is considered to play an important role in regulation and
differentiation of T cells and asthma (Kumar, Hitchins, & Foster, 2009; Runyon et al.,
2012). In particular, DNA methylation (DNA-M) may regulate genes associated with
asthma and allergy (Kim et al., 2010). Single nucleotide polymorphisms called
methylation quantitative trait loci (methQTLs) may influence the DNA-M at specific
CpG sites, which may be conditional of environmental exposures (Bell et al., 2011;
Hellman & Chess, 2010; Shoemaker, Deng, Wang, & Zhang, 2010). To reflect both the
genetic and the environmental influences, we call these loci conditional methQTLs.
The role of sex hormones and the gender-specific role of GATA3 in asthma motivated
us to study a possible interaction between oral contraceptives and GATA3 and further its
association with asthma. It is also important to understand whether the change in DNA-M
is a cause or a consequence of the disease. To address this issue we use a two stage model
proposed by Karmaus et al., which incorporates both methQTLs and genetic variants
(Karmaus, Ziyab, Everson, & Holloway, 2013). In stage one; we identify the conditional
methQTLs (influenced by the use of OCPs) that may result in a change of the DNA-M of
specific CpG sites of the GATA3 gene. These differentially methylated CpG sites by OCP
may modify the penetrance/activity of SNPs, which are then called modifiable genetic
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variants (modGV) (Malousi & Kouidou, 2012; Oberdoerffer, 2012). Therefore in stage
two, we evaluate the association between the differentially methylated CpG sites on the
modGVs and asthma at age 18 years.
Age at menarche is related to changes in endogenous sex hormones and reflects body
changes. In girls, the earlier the onset of puberty, the longer the exposure to sex
hormones. Hence, we reran our stage one model using age at menarche as an alternate
indicator of a possible endocrine effect. We believe that agreement of both exposures will
provide credence to our findings.
Methods
Study design and population
A whole population birth cohort was established in Isle of Wight, UK, in 1989 to
prospectively study the natural histories of asthma and allergic conditions. The local
research ethics committee approved the study and written informed consent was obtained
from 1456 children, who were followed up at ages 1, 2, 4, 10 and 18 years. The birth
cohort has been described in detail elsewhere (Arshad & Hide, 1992; Kurukulaaratchy et
al., 2003). Questionnaires were completed by the parents for each child at every followup. Blood samples were collected at age 18 years from 245 randomly selected female
offspring, and were stored for subsequent DNA analysis. In addition, in a small sample of
34 girls at 10 years of age, blood samples were collected to analyze DNA-M.
Exposures
Information on OCP was collected at age 18 years. The question was: „Are you on the
contraceptive pill?‟ Regarding age at menarche, we used the National Institute of Child
and Human Development (NICHD) questionnaire from the Study of Early Child Care
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and Youth Development, which is based on the Pubertal Development Scale (PDS)
method ("National Institute of Child and Human Development; NICHD Study of Early
Child Care and Youth Development"). Among other questions on pubertal signs, we
asked: „How old were you when you started to menstruate?‟
Outcome
Asthma information was collected using the International Study of Asthma and
Allergies in Childhood (ISAAAC) questionnaire (Asher et al., 1995). The question for
asthma was based on physician diagnosed asthma and the questions were as follows:
“history of physician diagnosed asthma?”, “wheezing or whistling in the chest in the last
12 months?” and “asthma treatment in the last 12 months?” Asthma at age 18 years was
defined by diagnosis of asthma plus current symptoms and/or asthma medication.
Genotyping
Genomic DNA was isolated from blood samples by using QIAamp DNA Blood Kits
(Qiagen, Valencia, Calif) or the ABI PRISM 6100 Nucleic Acid PrepStation (Applied
Biosystems, Foster City, Calif). Polymorphisms in the GATA3 gene were examined using
the SNPper and Applied Biosystems databases. Genotyping was conducted by
fluorogenic 5‟ nuclease chemistry PCR using Assays on Demands kits cycled on a
7900HT Sequence Detection System (Applied Biosystems, Foster City, CA), or biotinstreptavidin based pyro sequencing performed on PSQ- 6 instrumentation (Biotage AB,
Uppsala, Sweden). SNPs (n=17) that tagged the GATA3 gene were identified using a
tagger implemented in Haploview 4.2 using Caucasian Hapmap data, including 10 kb
upstream and downstream of the GATA3 gene (Barrett, Fry, Maller, & Daly, 2005).
Estimates of linkage disequilibrium (LD) between SNPs were calculated using D1 and r2.
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An r2 value of 0.85 was the threshold for tagging, and 7 SNPs were selected (1 SNP from
each of the 5 haplotype blocks and 2 SNPs that did not have strong linkage
disequilibrium with other SNPs, Figure 1).
DNA Methylation
DNA was extracted from the blood/saliva samples using a standard salting out
procedure (Miller, Dykes, & Polesky, 1988). DNA samples were interrogated using
GoldenGate Genotyping Assays (Illumina, Inc, SanDiego, CA, USA) on the BeadXpress
Veracode platform (Illumina, Inc, SanDiego, CA, USA) per Illumina‟s protocol. Data
were analyzed using the genotyping module of the GenomeStudio Software package
(Illumina, Inc, SanDiego, CA). The quality threshold for allele determination was set at a
GenCall score 0.25 (scores #0.25 were „„no calls‟‟) with 98.3% retained for further
analysis. One microgram DNA was bisulfite-treated for cytosine to thymine conversion
using the EZ 96-DNA methylation kit (Zymo Research, CA, USA), following the
manufacturer‟s standard protocol. Arrays were processed using a standard protocol as
described elsewhere (Bibikova, 2009). The Bead Chips were scanned using a Bead
Station, and the methylation level (beta (β) value) was calculated for each queried CpG
locus using Methylation Module of BeadStudio software.
Covariates
Maternal history of asthma and maternal smoking during pregnancy was assessed by a
questionnaire administered after birth. Information about the child‟s active smoking
status and their body mass indexes (BMI) were collected from the 18-year questionnaire
and anthropometric measurements conducted at age 18 years. „„Family social status
cluster‟‟ is a composite variable derived from a combination of family income, parental
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occupation (socioeconomic status) and number of children in a child‟s bedroom. The
British Registrar General‟s social classification grouping places professional occupations
in group 1 and unskilled manual occupations in group 5, with two subgroups within
group 3 (3.1= non-manual and 3.2 = manual). Family income at age 10 years was
recorded under six categories: class 1=less than £12 000; 2 = £12 000 to £17 999; 3 = £18
000 to £29 999, 4 = £30 000 to £41 999, 5 = £42 000 and greater. The number of children
who shared one bedroom ranged from 1 to 3. A cluster analysis of these three variables
yielded six groups, one clearly „„highest‟‟ and one clearly „„lowest‟‟ status, and four
„„middle‟‟ clusters representing a diversity of middle class living conditions (Ogbuanu,
Karmaus, Arshad, Kurukulaaratchy, & Ewart, 2009).
In addition, we adjusted the stage-one models for cell mixture using the method
proposed by Houseman et al (Houseman et al., 2012). This method identified CpG loci
from our data which were within differentially methylated regions known to distinguish
between white blood cell types, then utilized our Beta-values to predict the proportions of
CD8+ T-cells, CD4+ T-cells, natural killer cells, B-cells, monocytes and granulocytes for
each sample.
Statistical analysis
The preprocessing of the DNA-M data was done using the IMA (Wang D, 2012)
package implemented in the R statistical computing package ("R: A language and
environment for statistical computing. R Foundation for Statistical Computing.," 2012).
To identify tag-SNPs, linkage disequilibrium (LD) between SNPs was calculated using
D1 and r2 (Hill & Robertson, 2007) and they were tested for Hardy-Weinberg equilibrium
using Haploview 3.2 software (Barrett et al., 2005). To assess whether the subset
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population (n=245) represents the total cohort of girls at age 18 years chi square tests
were used. DNA-M levels were quantified using β values that present the proportion of
methylated (M) over the sum of methylated and unmethylated (U) sites (β=M/[C+M+U]),
with c being a constant to prevent dividing by zero (Kuan PF, 2010). As the β value
method has severe heteroscedasticity, it is recommended to use M-values for differential
methylation analysis (Du, 2010). A logit transformation was employed for all β-values to
normalize their distribution, which are then called M-values.
In our study, 16 CpG sites that spanned the GATA3 gene were analyzed, out of which
one CpG site was removed due to the presence of a probe SNP. Another CpG site was
removed because of the low methylation level (<0.05%). In addition, we tested in 34
female participants, to determine whether DNA-M from blood was stable between 10 and
18 years. Stability was estimated via the intraclass correlation coefficient (ICC).
The aim of the first stage of the two-stage model is to detect CpG sites that were affected
by an interaction of SNPs and OCP. We ran linear regression models, in which each of
the 14 CpG sites were modeled against seven SNPs, each interacting with OCPs. Since
we performed 98 tests (14  7) we adjusted for multiple testing using the FDR approach
(p= 0.05) (Benjamini & Hochberg, 1995).
Focusing on the CpG site(s) detected to OCPs, we then reran the analyses of stage 1
using age at menarche as exposure. This allowed us to check whether we can find similar
associations with CpG sites with another marker of endocrine changes.
In the second stage with asthma as a categorical variable, we used log-linear models
(GENMOD procedure in SAS 9.3) to estimate statistical interactions between the
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methylation level of selected CpG sites (from stage 1) and the GATA3 SNPs on the risk
for asthma at age 18 years.
In these models, confounders include maternal history of asthma, maternal smoking
during pregnancy, BMI at age 10 and 18, smoking at age 18, and prior socioeconomic
status. All confounders were simultaneously entered as covariates into the log-linear
model. Those that changed the association of interest by 10% or more were retained as
confounders in the final model. All tested hypotheses were penalized for multiple testing
using the FDR. We tested the CpG sites associated with OCP with another exposure,
which similarly indicates endocrine changes, namely age at menarche. The statistical
analyses were performed using the SAS statistical package (version 9.3; SAS Institute,
Cary, NC, USA).
Results
There were no significant differences in the prevalence of asthma, BMI at age 10
years, BMI, and smoking at 18 years, maternal history of asthma, socioeconomic status,
early menarche and OCP use between female offspring of the whole cohort (n=750) and
those who were randomly selected for the DNA-M analysis (n=245;Table 1). Among the
female participants with available methylation data, 12% had maternal history of asthma,
19% had mothers that smoked during pregnancy, 14.3% (35/245) had asthma at age 18
years, 48% used OCPs at age 18, and the median age at menarche was found to be 13
years. Use of oral contraceptives and age at menarche in our sample are significantly
associated (Wilcoxon test: p=0.001). 62% of the participants with age at menarche ≤ 11
years, 45.8% of those between 12 to 14 years, and 36% of those with ≥14 years used
OCPs (data not shown).
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Of the 13 SNPs that were genotyped, 7 SNPs (rs1269486, rs3802604, rs3824662,
rs422628, rs434645, rs12412241, and rs406103) were selected for further analysis since
these were uncorrelated (Figure 1). Of the 7 SNPs that were analyzed, only rs1269486
spanned the promoter region, followed by four SNPs (rs3802604, rs3824662, rs422628,
and rs406103) in the intron region, and the two other SNPs (rs434645, and rs12412241)
in the downstream of GATA3 gene (Table 2). Interestingly, the mean methylation (ßvalue, %) of six of the 14 CpG sites of the GATA3 gene was low (<.10; Table 3), four
were higher methylated (>0.90), and another four ranged between >0.10 and <0.55.
In stage one, after controlling for cell type composition in peripheral blood using the
Houseman formula (Houseman et al., 2012), the interaction term „OCP use  rs1269486‟
was found to be associated with differential methylation of cg17124583 (p-value=0.002;
FDR p-value = 0.04; table 4), indicating that rs1269486 represents a conditional
methQTL. OCP users with the „AA‟ (the difference in a logit scale is -0.86; pvalue=0.03) and „AG‟ (the difference in a logit scale is -0.57; p-value=0.002) genotypes
for rs1269486 had decreased methylation compared to those with the „GG‟ genotype. The
association was adjusted for potential confounders including the socioeconomic status,
maternal smoking during pregnancy, smoking at age 18, and BMI at age 18. However,
none changed the interaction effect by more than 10 percent.
To replicate our significant OCP model with an alternate indicator for endocrine
effects, we investigated whether we can see a similar effect with age at menarche (Table
4). Cg17124583 was also differentially methylated by the interaction of same SNP
rs1269486 and age at menarche. Methylation levels at cg17124583 are found to be
increased with every one year increase in age at menarche, in those with the „AA‟ and
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„AG‟ genotypes for rs1269486. However, the interaction remained statistically significant
only in those with the „AA‟ genotype (the difference in a logit scale is 0.42; p-value
=0.003). Finally, both OCP use and age at menarche, in interaction with rs1269486
showed a differential methylation of cg17124583.
Interestingly, in a small sample of 34 paired DNA-M measurements, the differentially
methylated CpG site cg17124583 show some variability from age 10 to age 18 (test for
stability: ICC=0.39, p=0.01) with mean methylation levels of 0.06 and 0.05, respectively.
This CpG site shows both stability and variability, but the variability is not explained,
either by OCP use or by age at menarche (data not shown). Also, there were no main
effects for the OCP use and the SNP rs1269486 of the GATA3 gene on the risk for asthma
at age 18 years.
In the second stage, we analyzed whether the OCP fingerprint on the differentially
methylated CpG site cg17124583 modifies the association between SNPs (modGVs) and
asthma at age 18. We tested the interaction between seven SNPs and the methylation
levels of cg17124583 (differentially methylated in stage 1), and its association with
asthma at age 18. We found statistically significant interactions between SNPs rs434645,
and rs422628 and cg17124583 that modify the risk of asthma at age 18 (Table 5). For
rs434645, we combined the „AA and AG‟ genotypes since the direction of effect on
methylation is same for both, and checked its interaction with cg1712583 and its
association with asthma at age 18, using „GG‟ as the reference. The interaction was found
to be significant (p= 0.01; Table 5), however, it did not survive multiple testing with
FDR. For the SNP rs422628, we used the co-dominant model and compared participants
who had the „AG‟ and „GG‟ genotypes, with those who have „AA‟ genotype. The
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interaction term „cg17124583 x rs422628‟ was found to be statistically significant in
those with the heterozygous genotype after adjusting for multiple comparisons (p=
0.0045; FDR adjusted p=0.03; Table 5). The DNA-M level range for cg17124583 was
0.01 to 0.46. Since the number of participants at methylation levels of 0.02 or less and
0.14 or more were less, we grouped these methylation levels into ≤0.02 (n=4) and ≥0.14
(n=9). Descriptively, 157 participants had methylation levels of 0.05 and less,
71participants of 0.06 to 0.09, and 17 participants of 0.1 to 0.46. For the „AG‟ genotype,
compared to „AA‟, we found that at methylation levels of 0.02, 0.04, 0.06, 0.08, 0.10, and
0.12, the RRs of asthma were 0.31, 0.61, 1.21, 2.42, 4.83, and 9.64 respectively (Figure
2). The risk of asthma linked with the rs422628 „AG‟ genotype compared to „AA‟
increases as methylation of cg17124583 increases.
Discussion
Of the 14 CpGs and the seven SNPs that were analyzed, we identified a conditional
methQTL (rs1269486) interacting with OCPs and with age at menarche leading to a
differential DNA-M of cg17124583. The same differentially methylated CpG site
cg17124583 in interaction with another SNP rs422628 was found to modify the
association of asthma at age 18 years. This association remained statistically significant
after adjusting for multiple comparisons using the FDR. This is the first study to identify
SNPs on the GATA3 gene, which in interaction with oral contraceptive use, and with age
at menarche, are associated with differential methylation of GATA3 CpG sites.
Although the CpG site cg17124583 is located 13,768 base pairs away from rs422628, we
can see that the risk of asthma is modulated by this CpG site. It is possible that the SNP is
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in linkage disequilibrium with a genetic variant adjacent to the cg17124583. Such an
explanation was recently shown in another study (Grundberg et al., 2013).
The probability of a selection bias is minimal in our study as the study participants
were randomly selected for the DNA-M analysis and no significant differences were
found between the study population and the whole cohort. As the information on the use
of OCPs is self-reported by the participants, there is a possibility of a recall bias.
However, previous studies have shown high agreement between questionnaire data and
medical records for any OCP use, current use, and time since first use (Bean, Leeper,
Wallace, Sherman, & Jagger, 1979; Norell, Boethius, & Persson, 1998). We repeated the
analyses with a different exposure marker, namely age at menarche, which showed
similar result.
Age at menarche is an important event in a women‟s life, thus, recall bias also is
considered to be minimal (Must et al., 2002). In addition, since women were neither
aware of their SNPs nor the methylation status, a recall bias would result in a nondifferential misclassification and likely underestimate the true association.
The DNA-M profiles in our study are obtained by using the Infinium Human Methylation
450 array, which is demonstrated to have high validity and high reproducibility (Bibikova
et al., 2011). As DNA-M is established with tissue specific patterns, it is important to
consider whether the DNA-M obtained from peripheral blood represents the methylation
in other tissues, and is currently under debate (Heijmans & Mill, 2012; Ma et al., 2014;
Talens & Putter, 2010; Terry, Delgado-Cruzata, Vin-Raviv, Wu, & Santella, 2011). In
addition, peripheral blood leukocyte represents a mixture of cells (Houseman et al.,
2012). Using CpG site information, we estimated the relative contribution of cell type
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composition in peripheral blood using the Houseman approach (Houseman et al., 2012).
The estimated cell type composition had only a minor influence on the DNA-M of
GATA3 CpG sites.
In the regression models, we observed that, although the main effects of OCP, age at
menarche, and SNPs were not significantly associated with DNA-M of cg17124583, their
interactions were found to be significantly associated even after penalizing for multiple
testing. Similarly, no main effects were seen for the association of OCP, cg17124583,
and the SNPs on the risk for asthma at age 18. However, the interaction of the SNP and
DNA-M were found to be statistically significant.
Asthma being considered a „Th2-disease‟, we focused on the GATA3 gene because it
is known to be the master regulator of Th2 cell differentiation (Zheng & Flavell, 1997)
and has been linked to endocrine responses (Parikh, Palazzo, Rose, Daskalakis, &
Weigel, 2005). Estrogen is an immune modulator and is known to stimulate the
production of Th2 cytokines which include IL-4, IL-5, and IL-13 (Ana Paula Ligeiro de
Oliveira et al., 2007; Cai et al., 2012). Our findings show that OCP use modifies the
DNA-M of GATA3 gene. We speculate that OCPs, which also contain estrogen and
progesterone (Miyaura & Iwata, 2002; Salem, 2004), may influence Th2 cytokine
production via the differential methylation of GATA3 gene. Also similar findings are seen
with age at menarche altering the DNA-M of GATA3 gene. Statistically, although early
age at menarche is related to use of OCP, the two variables are not in complete agreement
and seem to measure different features. Age at menarche is known to be related to
endogenous sex hormones (Apter, Reinila, & Vihko, 1989) and OCP to exogenous sex
hormones. We believe that the agreement of our stage one findings between OCP use and
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age at menarche provides credence to our results. Our two stage model suggests a
potential pathway from exposures such as OCP and age at menarche altering the DNA-M
of GATA3 to subsequently changes in the risk for asthma at age 18 years.
A limitation of our study is that the RRs at methylation levels larger than 9% are high,
which is due to the limited number of individuals (n=17) with methylation levels larger
than 9%. Another limitation is the lack of availability of the information on the type of
OCP (estrogen/progesterone only pills or a combined pill), which can further help to
elucidate the role of either estrogen/progesterone or both in genetic polymorphisms and
on asthma.
Conclusion
The present study findings suggest a potential pathway in which OCP exposure and
age at menarche may alter the DNA-M of GATA3 CpG site, which subsequently may
influence the risk of asthma at age 18 years. These findings may provide one among
multiple explanations for the gender differences in asthma after puberty. However, a
replication of our findings is warranted. This study represents the first report of an
association of the interaction of SNP and DNA-M of GATA3 on the risk for asthma at age
18 years, that is modified by the use of OCP and age at menarche. Also, this study
provides the motivation for other researchers to search for interactions between genetic
variants, sex hormones, and DNA-M, in particular to explain the gender shift in asthma
after puberty.
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Appendices

Table 1
Subjects’ Characteristics with Available Methylation Data Compared to the Female
Participants of the Total Cohort

Factors
Maternal smoking during
pregnancy
Yes
No
Missing
Maternal history of asthma
Yes
No
Missing
Asthma at age 18 years
Yes
No
Missing
Oral contraceptive use at
age 18 years
Yes
No
Missing
Smoking at age 18 years
Yes
No
Missing
Socioeconomic status
High
Medium
Low
Missing
Body mass index at age 18
years (kg/m2)
Missing
Age at menarche
Missing

Total female
participants
n (%)
n=750

Female participants with
DNA-M data
n (%)
n=245

188 (25.3)
555 (74.7)
7

47 (19.3)
197 (80.7)
1

0.055

80 (10.8)
662 (89.2)
8

30 (12.3)
213 (87.7)
2

0.50

128 (19.4)
531 (80.6)
91

35 (14.3)
210 (85.7)
0

0.07

293 (46.7)
335 (53.3)
122

117 (48
126 (52)
2

0.75

192 (29.7)
455 (70.3)
103

63 (25.8)
181(74.2)
1

0.29

50 (7.4)
520 (77.3)
103 (15.3)
77
n (Median; 5, 95%)
499 (22.2;18.2, 32)

22 (9.1)
182 (74.6)
37 (15.2)
1

251
631(13.0;11.0,15.0)
119
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P value

0.69

240 (22.9;19.05, 32.93)

0.56

5
233 (13.0; 10.0, 15.0)
12

0.32

Table 2
Single Nucleotide Polymorphisms (SNPs) for GATA3 and their Genotypes
SNP
Position
Location
Genotype
Frequency (%)
8096199
Promoter
AA
13 (5.7)
rs1269486
AG
87 (37.8)
GG
130 (56.5)
Total
230 (100.0)
8102272
Intron
AA
88 (38.4)
rs3802604
AG
103 (45.0)
GG
38 (16.6)
Total
229 (100.0)
8104208
Intron
AA
8 (3.4)
rs3824662
AC
69 (29.6)
CC
156 (67.0)
Total
233 (100.0)
8111409
Intron
AA
128 (55.0)
rs422628
AG
93 (39.9)
GG
12 (5.1)
Total
233 (100.0)
8111621
Intron
AA
13 (5.6)
rs406103
(boundary)
AG
78 (33.5)
GG
142 (60.9)
Total
233 (100.0)
8121451
Downstream
AA
4 (1.7)
rs434645
AG
67 (29.3)
GG
158 (69.0)
Total
229 (100.0)
8127139
Downstream
AA
19 (8.1)
rs12412241
AG
92 (39.7)
GG
121 (52.1)
Total
232 (100.0)
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Table 3
Distribution of Methylation on CpG Sites of GATA3 Gene
CpG site
Location
Coordinate Mean Methylation
cg18599069
5'UTR
8096991
0.06
cg10008757
5'UTR
8097183
0.07
cg14327531
5'UTR
8097331
0.06
cg17124583
Body
8097641
0.05
cg19883813a
Body
8098005
0.04
cg11430077
Body
8099018
0.11
cg01255894
Body
8099218
0.06
cg10089865
Body
8100286
0.93
cg22770911
Body
8101307
0.52
cg04492228
Body
8101513
0.19
cg17489908
Body
8101566
0.25
cg03669298
Body
8102210
0.06
cg00463367
Body
8103673
0.20
cg04213746
Body
8106003
0.95
cg27409129
Body
8111731
0.93
cg07989490b 3'UTR
8117026
0.95
a
CpG site is deleted because of a low methylation level (<5%)
b
CpG site is deleted because of a probe SNP
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5%
0.04
0.05
0.04
0.02
0.02
0.05
0.03
0.91
0.44
0.13
0.17
0.04
0.11
0.93
0.92
0.94

95%
0.07
0.09
0.08
0.10
0.08
0.20
0.09
0.95
0.60
0.26
0.34
0.09
0.31
0.96
0.94
0.97

Table4
Assessment of Interaction of Single Nucleotide Polymorphisms with Oral Contraceptive
Use, and with Age at Menarche on the Methylation of the CpG Site cg17124583 using
Linear Regression&
Parameter
Estimate (Standard error)
P value
Not adjusted
Adjusted
Not adjusted
Adjusted
for
for
for
for
cell type
cell type
cell type
cell type#
0.12 (0.11)
0.16 (0.11)
0.28
0.16
OCP use
rs1269486

OCP use 
rs1269486

AA

0.64 (0.24)

0.68 (0.25)

0.009

0.006

AG
GG

0.41 (0.12)
Reference

042 (0.13)

0.001

0.001

AA

-0.72 (0.39)

-0.86 (0.40)

0.06

0.03

AG
GG

-0.55 (0.18)
Reference

-0.57 (0.18)

0.002

0.002

-0.09 (0.04)

-0.09 (0.04)

0.05

0.06

-5.28 (1.77)
-1.12 (0.86)
Reference

-4.87 (1.78)
-1.06 (0.86)

0.003
0.19

0.006
0.21

Age at menarche
rs1269486

AA
AG
GG

Age at menarche 
rs1269486

AA
0.45 (0.14)
0.42 (0.14)
0.001
0.003
AG
0.09 (0.06)
0.09 (0.06)
0.14
0.16
GG
Reference
&
Adjusted for socioeconomic status, smoking at age 18, and BMI at age 18
#
Additionally adjusted for cell mixture of the peripheral blood using the Houseman
formula (Houseman et al., 2012)
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Table5
Log-Linear Model of Interaction between Genetic Variants with DNA Methylation of the
GATA3 Gene on the occurrence of Asthma at Age 18 Years#
Parameter
95% CI
P value
Estimate
cg17124583
-22.19
rs422628
AG
-1.87
-3.26 -0.48
0.008
GG
-0.68
-3.83 2.47
0.67
AA
Reference
34.49
10.7 58.27
0.004
cg17124583  rs422628 AG
GG
-1.86
-60.69 56.96
0.95
AA
Reference
rs434645

AA and AG
-1.11
-2.47 0.25
0.11
GG
Reference
31.13
-6.68 55.59
0.01
cg17124583  rs434645 AA and AG
GG
Reference
#
Adjusted for socioeconomic status, maternal smoking during pregnancy, smoking at age
18, and BMI at age 18

The estimate needs to be exponentiated to calculate the risk ratio. In addition, to
estimate the risk ratio due to the interaction, we need to take the two main effects and the
interaction effect into account. The information is provided in Figure 2.
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Figure 1. Linkage Disequilibrium of GATA3 Single Nucleotide Polymorphisms
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Figure 2. Risk Ratio of Asthma at Age 18 Years Versus Methylation at Different
Genotypes of GATA3rs422628
The blue bars present the relative frequency of the DNA methylation levels. For instance,
4% methylation is found in 28% of the participants. The reference genotype is „AA‟,
which is a solid horizontal line that indicates a risk ratio value of 1.
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